# Trade Mark Journal No.2026/018 1 May 2026

## WO0000001912899 (5,42)

Office of origin: United States of America

Date of International Registration:5 March 2026
Date of designation in the UK: 5 March 2026

Class 5
  Therapeutic agents for the diagnosis, treatment and prevention of diseases and disorders, namely, fibrosis, autoimmune disease, cancer, diseases of metabolism, and musculoskeletal disorders; therapeutic antibodies for the diagnosis, treatment and prevention of fibrosis, autoimmune disease, cancer, diseases of metabolism, and musculoskeletal disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of fibrosis, autoimmune disease, cancer, diseases of metabolism, and musculoskeletal disorders.
Class 42
  Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic products.

Scholar Rock, Inc.

Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA